Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Rusakiewicz · SciRah

Researcher profile · Semantic Scholar

S. Rusakiewicz

Share profile

S. Rusakiewicz — researcher profile on SciRah

h-index: 36
Works: 87
Citations: 10K

Most-cited papers

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
M. Vetizou, J. Pitt, R. Daillère, P. Lepage +34 more
2015Science3,186 citations Open access
Semantic Scholar
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.
R. Daillère, M. Vetizou, N. Waldschmitt, T. Yamazaki +32 more
2016Immunity769 citations Open access
Semantic Scholar
Cooperation between Constitutive and Inducible Chemokines Enables T-cell Engraftment and Immune Attack in Solid Tumors
D. Dangaj, M. Bruand, Alizée J. Grimm, C. Ronet +23 more
2019Cancer Cell740 citations Open access
Semantic Scholar
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
B. Besse, M. Charrier, V. Lapierre, É. Dansin +24 more
2015Oncoimmunology712 citations Open access
Semantic Scholar
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
E. Vacchelli, Yu-Ting Ma, E. Baracco, A. Sistigu +38 more
2015Science432 citations
Semantic Scholar
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
F. Herrera, C. Ronet, M. Ochoa de Olza, D. Barras +35 more
2021Cancer Discovery370 citations Open access
Semantic Scholar
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye, S. Rusakiewicz, I. Martins, C. Ménard +37 more
2011Nature Medicine340 citations Open access
Semantic Scholar
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.
S. Rusakiewicz, M. Semeraro, M. Sarabi, M. Desbois +28 more
2013Cancer Research290 citations
Semantic Scholar
Rationale for anti-OX40 cancer immunotherapy.
S. Aspeslagh, S. Postel-Vinay, S. Rusakiewicz, J. Soria +2 more
2016European Journal of Cancer280 citations
Semantic Scholar
A multicentre randomised phase III trial comparing pembrolizumab vs single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.
S. Popat, A. Curioni-Fontecedro, U. Dafni, R. Shah +19 more
2019Annals of Oncology226 citations Open access
Semantic Scholar
Predictors of responses to immune checkpoint blockade in advanced melanoma
N. Jacquelot, M. Roberti, D. Enot, S. Rusakiewicz +46 more
2017Nature Communications197 citations Open access
Semantic Scholar
Myeloid Antigen-Presenting Cell Niches Sustain Antitumor T Cells and License PD-1 Blockade via CD28 Costimulation
Jaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, D. Barras +32 more
2021Cancer Cell169 citations Open access
Semantic Scholar
Immunological off-target effects of imatinib
L. Zitvogel, S. Rusakiewicz, B. Routy, M. Ayyoub +1 more
2016Nature Reviews Clinical Oncology141 citations
Semantic Scholar
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
M. Semeraro, S. Rusakiewicz, V. Minard-Colin, Nicolas F. Delahaye +23 more
2015Science Translational Medicine140 citations
Semantic Scholar
NCR3/NKp30 contributes to pathogenesis in primary Sjögren’s syndrome
S. Rusakiewicz, G. Nocturne, T. Lazure, M. Semeraro +25 more
2013Science Translational Medicine127 citations Open access
Semantic Scholar
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
M. Bruand, D. Barras, M. Mina, E. Ghisoni +31 more
2021Cell Reports123 citations Open access
Semantic Scholar
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
D. Hannani, M. Vetizou, D. Enot, S. Rusakiewicz +27 more
2015Cell Research102 citations Open access
Semantic Scholar
Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma.
Lucas Ferrari de Andrade, S. Ngiow, Kimberley A Stannard, S. Rusakiewicz +7 more
2014Cancer Research97 citations Open access
Semantic Scholar
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
D. Hannani, M. Vetizou, D. Enot, S. Rusakiewicz +27 more
2015Cell Research94 citations Open access
Semantic Scholar
Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.
Meriem Messaoudene, G. Fregni, Emmanuelle Fourmentraux-Neves, J. Chanal +15 more
2014Cancer Research91 citations
Semantic Scholar
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer
Anne I. Kraemer, Chloé Chong, Florian Huber, Hui-Song Pak +13 more
2023Nature Cancer87 citations Open access
Semantic Scholar
Artificial exosomes as tools for basic and clinical immunology.
H. De la Peña, J. Madrigal, S. Rusakiewicz, M. Bencsik +5 more
2009JIM - Journal of Immunological Methods84 citations
Semantic Scholar
Desirable cell death during anticancer chemotherapy
C. Locher, R. Conforti, L. Aymeric, Yu-Ting Ma +9 more
2010Annals of the New York Academy of Sciences77 citations
Semantic Scholar
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
J. Schmidt, Johanna Chiffelle, Marta A. S. Perez, Morgane Magnin +28 more
2023Nature Communications69 citations Open access
Semantic Scholar
18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer
Mario Jreige, I. Letovanec, K. Chaba, S. Renaud +11 more
2019European Journal of Nuclear Medicine and Molecular Imaging64 citations
Semantic Scholar
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
N. Jacquelot, D. Enot, C. Flament, N. Vimond +26 more
2016Journal of Clinical Investigation63 citations Open access
Semantic Scholar
Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy
G. Boivin, Pradeep Kalambaden, julien Faget, S. Rusakiewicz +5 more
2018Frontiers in Oncology59 citations Open access
Semantic Scholar
Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy
E. Vacchelli, M. Semeraro, D. Enot, K. Chaba +10 more
2015OncoTarget59 citations Open access
Semantic Scholar
A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
S. Popat, A. Curioni-Fontecedro, V. Polydoropoulou, R. Shah +16 more
2019Annals of Oncology52 citations Open access
Semantic Scholar
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
S. Rusakiewicz, A. Perier, M. Semeraro, J. Pitt +40 more
2017Oncoimmunology48 citations Open access
Semantic Scholar
A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription
A.-S. Musahl, X. Huang, S. Rusakiewicz, E. Ntini +4 more
2015Oncogene46 citations Open access
Semantic Scholar
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnès, Meriem Messaoudene, G. Stoll, B. Routy +22 more
2017Oncoimmunology42 citations Open access
Semantic Scholar
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients.
M. Charrier, L. Mezquita, B. Lueza, L. Dupraz +14 more
2019European Journal of Cancer39 citations Open access
Semantic Scholar
Potent immunomodulatory effects of the trifunctional antibody catumaxomab.
D. Goéré, C. Flament, S. Rusakiewicz, V. Poirier-Colame +7 more
2013Cancer Research38 citations Open access
Semantic Scholar
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer
Laetitia Fend, S. Rusakiewicz, J. Adam, B. Bastien +12 more
2017Oncoimmunology37 citations Open access
Semantic Scholar
Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering.
A. Romero, N. Chaput, V. Poirier-Colame, S. Rusakiewicz +18 more
2014Cancer Research37 citations Open access
Semantic Scholar
Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response
S. Delluc, P. Hachem, S. Rusakiewicz, A. Gaston +8 more
2009Cancer Immunology and Immunotherapy35 citations
Semantic Scholar
Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis
N. Jacquelot, M. Roberti, D. Enot, S. Rusakiewicz +16 more
2016Journal of Investigative Dermatology34 citations Open access
Semantic Scholar
Immunotherapeutic peptide vaccination with leukemia-associated antigens.
S. Rusakiewicz, J. Molldrem
2006Current Opinion in Immunology31 citations
Semantic Scholar
Natural killer cell mediated immunosurveillance of pediatric neuroblastoma
M. Semeraro, S. Rusakiewicz, L. Zitvogel, G. Kroemer
2015Oncoimmunology30 citations Open access
Semantic Scholar
Natural killer cells in non-hematopoietic malignancies
M. Desbois, S. Rusakiewicz, C. Locher, L. Zitvogel +1 more
2012Front. Immun.28 citations Open access
Semantic Scholar
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes
S. Adams, Alizée J. Grimm, C. Chiang, Ananda Mookerjee +14 more
2020Journal for ImmunoTherapy of Cancer25 citations Open access
Semantic Scholar
NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution
Meriem Messaoudene, G. Fregni, D. Enot, N. Jacquelot +11 more
2016Oncoimmunology25 citations Open access
Semantic Scholar
Phase I clinical trial combining imatinib mesylate and IL-2
N. Chaput, C. Flament, C. Locher, M. Desbois +12 more
2013Oncoimmunology25 citations Open access
Semantic Scholar
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment.
P. Gannon, A. Harari, Aymeric Auger, Clément Murgues +17 more
2020Cytotherapy24 citations
Semantic Scholar
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma
N. Jacquelot, J. Pitt, D. Enot, M. Roberti +4 more
2017Oncoimmunology23 citations Open access
Semantic Scholar
Hydrogen peroxide: a potent cytotoxic agent effective in causing cellular damage and used in the possible treatment for certain tumours.
M. Symons, S. Rusakiewicz, Robert C. Rees, Shamim I. Ahmad
2001Medical Hypotheses23 citations
Semantic Scholar
Melanoma and immunotherapy bridge 2015
V. Nanda, Weiyi Peng, P. Hwu, M. Davies +384 more
2016Journal of Translational Medicine22 citations Open access
Semantic Scholar
The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation
M. Tuthill, Frederick Chen, S. Paston, H. De la Peña +2 more
2009Cancer Immunology and Immunotherapy22 citations Open access
Semantic Scholar
Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort
N. Prada, Guillemette Antoni, F. Commo, S. Rusakiewicz +6 more
2013Oncoimmunology21 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Zitvogel×30
Invite
L. Zitvogel — researcher profile on SciRah
G. Kroemer×18
Invite
G. Kroemer — researcher profile on SciRah
D. Enot×15
Invite
D. Enot — researcher profile on SciRah
A. Eggermont×13
Invite
A. Eggermont — researcher profile on SciRah

×13

Invite

M. Semeraro — researcher profile on SciRah

V. Poirier-Colame×12

Invite

V. Poirier-Colame — researcher profile on SciRah

N. Jacquelot×12

Invite

N. Jacquelot — researcher profile on SciRah

Invite

N. Chaput — researcher profile on SciRah

Invite

C. Flament — researcher profile on SciRah

Invite

G. Coukos — researcher profile on SciRah

Invite

A. Caignard — researcher profile on SciRah

Invite

M. Roberti — researcher profile on SciRah